LeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on October 29, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced it will release its third quarter 2020 financial results on October 29, 2020, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced it will release its third quarter 2020 financial results on October 29, 2020, after market close. A conference call is scheduled for 5:00 PM EDT that day to discuss the financial results and the company's outlook. Interested parties can join the call at 844-239-5284 or access the live webcast through their investor relations website.
LeMaitre Vascular specializes in devices for the treatment of peripheral vascular disease, a condition impacting over 200 million people globally.
Positive
- Scheduled release of Q3 2020 financial results indicates transparency.
- Conference call planned, providing investors insight into company outlook.
Negative
- None.
Details
News Market Reaction – LMAT
The recorded move for LMAT in the trading session of this news was -0.36%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Oct. 09, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 4052529. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company’s diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
Contact
LeMaitre Vascular, Inc.
Sandra Millar
+1-781-425-1686
smillar@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.